Jump Financial’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-18,989
Closed -$2.59M – 2592
2026
Q2
$2.59M Buy
+18,989
New +$2.33M 0.02% 783
2025
Q4
– Sell
-23,086
Closed -$3.09M – 2230
2025
Q3
$3.09M Buy
+23,086
New +$2.8M 0.04% 559
2025
Q2
– Sell
-2,694
Closed -$343K – 2100
2025
Q1
$343K Buy
+2,694
New +$415K ﹤0.01% 1240
2024
Q2
– Sell
-6,498
Closed -$1.2M – 2183
2024
Q1
$1.2M Buy
+6,498
New +$1.24M 0.03% 695
2023
Q3
– Sell
-54,155
Closed -$7.66M – 2179
2023
Q2
$7.66M Buy
+54,155
New +$8.68M 0.28% 51
2022
Q4
– Sell
-2,691
Closed -$504K – 1962
2022
Q3
$504K Sell
2,691
-117
-4% -$24.7K 0.02% 900
2022
Q2
$456K Sell
2,808
-7,489
-73% -$1.18M 0.02% 898
2022
Q1
$1.94M Buy
10,297
+8,054
+359% +$1.53M 0.08% 299
2021
Q4
$594K Buy
+2,243
New +$604K 0.04% 577
2020
Q4
– Sell
-3,984
Closed -$588K – 1139
2020
Q3
$588K Hold
3,984
– – 0.12% 270

Other funds holding RGEN

Jump Financial's RGEN Position: Q3 2026 in Review

Jump Financial sold out of Repligen (RGEN) in Q3 2026, closing a stake of 18,989 shares — an estimated $2.59M sold.

Jump Financial first reported a position in RGEN in Q3 2020 and held it in 10 quarters. The position peaked at $7.66M in Q2 2023. 525 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Jump Financial reported no remaining Repligen position as of Q3 2026 after selling out during the quarter.
  • Jump Financial sold 18,989 Repligen shares in Q3 2026, an estimated $2.59M.
  • Jump Financial first reported a position in Repligen in Q3 2020 and held it in 10 quarters.
  • Jump Financial's Repligen position peaked at $7.66M in Q2 2023.
  • 525 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.